RxSpark
PrivateCompany Overview
RxSpark is a healthcare technology company that provides a pharmacy discount platform and prescription price comparison tool to help patients save on medications.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, E-commerce
Business Model
B2C
Customer Profile
Marketplace Commission, Revenue Share
AI Layer
Non-AI
Keywords
prescription drug pricesprescription discount cardpharmacy coupondrug price comparisongoodrx alternativemedication savingspharmacy benefit managerPBMprescription savingsdigital health platformout-of-pocket costswhite-label health toolstelemedicine partner
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxSpark Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
RxSpark Funding Rounds
Historical fundraising activity
RxSpark Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Appia Ventures | Private Equity |
RxSpark Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxSpark's valuation, stock price, and market status.
Firmographic Details
HeadquartersAlpharetta, Georgia
Employee Range4
Year Founded2016
Last Funding—